NextPlat (NASDAQ:NXPL) Upgraded at Zacks Research

NextPlat (NASDAQ:NXPL) was upgraded by equities researchers at Zacks Research to a “hold” rating in a research report issued on Thursday,Zacks.com reports.

A number of other equities research analysts also recently weighed in on NXPL. Weiss Ratings upgraded NextPlat from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, May 11th. Litchfield Hills Research initiated coverage on shares of NextPlat in a research report on Wednesday. They set a “buy” rating and a $11.00 price objective for the company. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $11.00.

NextPlat Price Performance

NXPL stock opened at $6.15 on Thursday. The company has a quick ratio of 2.12, a current ratio of 2.56 and a debt-to-equity ratio of 0.05. The firm has a market cap of $16.67 million, a price-to-earnings ratio of -1.42 and a beta of 1.90. The company’s fifty day simple moving average is $6.39 and its 200 day simple moving average is $5.93. NextPlat has a 12-month low of $3.38 and a 12-month high of $11.10.

NextPlat (NASDAQ:NXPL) last posted its quarterly earnings data on Thursday, May 14th. The company reported ($0.42) earnings per share for the quarter. The business had revenue of $9.86 million during the quarter. NextPlat had a negative return on equity of 58.05% and a negative net margin of 23.14%. On average, analysts expect that NextPlat will post -0.55 earnings per share for the current year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in NextPlat stock. Citadel Advisors LLC acquired a new stake in NextPlat Corp. (NASDAQ:NXPL) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned 0.19% of NextPlat as of its most recent filing with the Securities & Exchange Commission. 1.30% of the stock is owned by institutional investors.

Key Stories Impacting NextPlat

Here are the key news stories impacting NextPlat this week:

• Positive Sentiment: Litchfield Hills Research initiated coverage on NextPlat with a Buy rating and a $11.00 price target, suggesting substantial upside potential. Street Insider article
• Positive Sentiment: The analyst sees NextPlat moving toward profitability, forecasting FY2027 EPS of $0.57 and positive quarterly EPS in 2027, which may improve longer-term sentiment. Benzinga article
• Neutral Sentiment: New earnings estimates for FY2026 (-$0.55 EPS) and Q2 2026 (-$0.21 EPS) still indicate losses in the near term, limiting immediate upside. Tickerreport article
• Neutral Sentiment: Short interest data showed a decline earlier in the month, but the most recent update reported 0 shares short, making the data unusual and hard to interpret for trading impact. American Banking News article
• Negative Sentiment: The latest analyst estimates still call for losses through most of 2026, including Q3 2026 EPS of $0.00 and Q4 2026 EPS of $0.07, so investors may remain cautious about near-term earnings power. Benzinga article

About NextPlat

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.